Adjuvant radiotherapy in patients post radical prostatectomy with tumor extending through capsule or positive seminal vesicles

Urology

Volumn 39, Issue 1, 1992, Pages 59-62

  Stein, Avi ^a,b   Dekernion, Jean B ^a,b   Dorey, Frederick ^a,b   Smith, Robert B ^a,b  

^a Division of Female Urology Reconstructive Surgery and Urodynamics   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; ARTICLE; CANCER SURVIVAL; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSTATE CARCINOMA; PROSTATECTOMY; SEMINAL VESICLE;

AGED; COMBINED MODALITY THERAPY; FOLLOW-UP STUDIES; GENITAL NEOPLASMS, MALE; HUMAN; MALE; NEOPLASM INVASIVENESS; PROSTATECTOMY; PROSTATIC NEOPLASMS; RETROSPECTIVE STUDIES; SEMINAL VESICLES; SUPPORT, NON-U.S. GOV'T; SURVIVAL RATE;

EID: 0026569799     PISSN: 00904295     EISSN: 15279995     Source Type: Journal    
DOI: 10.1016/0090-4295(92)90043-V     Document Type: Article

References (14)

1. Understaging and undergrading of prostate cancer
2. Radical prostatectomy for stage B2 prostatic cancer
3. External beam radiation salvage for residual or recurrent local tumor following radical prostatectomy
4. Prognosis of patients with D1 prostate carcinoma following radical prostatectomy with and without early endocrine therapy
5. Definitive radiotherapy following radical prostatectomy: results and complications
6. Postoperative radiotherapy of the prostate for patients undergoing radical prostatectomy with positive margins, seminal vesicle involvement, and/or penetration through the capsule
7. Postoperative radiotherapy for patients with carcinoma of the prostate undergoing radical prostatectomy with positive surgical margins, seminal vesicle involvement and/or penetration through the capsule
8. Radiation therapy as adjuvant treatment after radical prostatectomy
9. Postoperative radiation therapy for pathological stage C prostate cancer
10. Prostate-specific antigen in the diagnosis and treatment of adenocarcinoma of the prostate. II. Radical prostatectomy-treated patients
11. Clinical use of prostate-specific antigen in patients with prostate cancer
12. Adjuvant radiation therapy in patients with detectable prostatic specific antigen following radical prostatectomy (Abstr. 508)
13. Effects of adjuvant radiation therapy on prostate-specific antigen following radical prostatectomy
14. Adjuvant radiotherapy following radical prostatectomy: results and complications